Reaction

Acinetobacter Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,069 reports · 78 co-occurring drugs

As of the last recalculation, Acinetobacter Infection appears in 1,069 FAERS reports alongside 78 co-occurring drug terms. The strongest observed disproportionality signal is MEROPENEM (PRR 82.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Meropenem	121	82.7	83.0
Ganciclovir Sodium	31	58.7	58.9
Ganciclovir	30	58.7	58.9
Moxifloxacin	35	50.0	50.1
Valganciclovir Hydrochloride Powder,	30	49.2	49.4
Amikacin	35	41.3	41.4
Vancomycin	109	40.8	40.9
Gentamicin	26	39.6	39.7
Basiliximab	23	38.9	39.0
Amphotericin B	24	38.1	38.2
Vancomycin Hydrochloride	112	36.8	36.9
Moxifloxacin Hydrochloride	37	36.8	36.8
Anti-Thymocyte Globulin (Rabbit)	15	36.7	36.8
Valganciclovir	33	35.1	35.2
Valganciclovir Hydrochloride	33	35.1	35.2
Gentamicin Sulfate	26	32.8	32.9
Piperacillin Sodium And Tazobactam Sodium	32	32.7	32.8
Piperacillin And Tazobactam	21	32.6	32.6
Oseltamivir	13	32.2	32.2
Tacrolimus Ointment 0.1%	171	31.6	31.7
Tacrolimus Extended-Release Capsules	171	31.6	31.6
Sirolimus	21	30.9	31.0
Ampicillin	13	30.9	31.0
Ampicillin Sodium	13	30.9	31.0
Cefazolin	13	28.1	28.1
Ceftriaxone	45	27.8	27.9
Mycophenolate Mofetil	165	27.8	27.8
Mycophenolate Mofetil Hydrochloride	165	27.7	27.8
Methylprednisolone	167	27.7	27.7
Piperacillin Sodium,Tazobactam Sodium	36	27.3	27.3
Rifampicin	14	27.3	27.3
Linezolid	40	27.1	27.2
Tacrolimus	182	27.1	27.1
Voriconazole Injection	29	26.7	26.7
Ceftriaxone Sodium	50	26.6	26.6
Cefepime	19	26.3	26.3
Cefazolin Sodium	16	26.2	26.3
Mycophenilic Acid	26	25.0	25.0
Cefuroxime	14	24.1	24.2
Cefepime Hydrochloride	19	23.4	23.4
Micafungin Sodium	10	23.2	23.2
Fluconazole	77	23.0	23.0
Norepinephrine	12	22.1	22.1
Metronidazole Topical	51	21.8	21.9
Norepinephrine Bitartrate	15	20.6	20.6
Voriconazole	31	20.4	20.5
Tobramycin Solution	12	19.7	19.7
Tobramycin Sulfate	12	19.1	19.1
Mycophenolic Acid	30	18.7	18.8
Itraconazole	11	18.5	18.5
Isoniazid	15	18.3	18.3
Metronidazole	55	17.6	17.6
Pyrazinamide	8	16.7	16.7
Busulfan	13	16.3	16.3
Ciprofolxacin	56	16.0	16.0
Ciprofloxacin Tablets	56	16.0	16.0
Clobetasol Propionate Ointment Usp, 0.05%	8	15.2	15.2
Clobetasol Propionate	8	15.2	15.2
Clarithromycin	22	12.7	12.7
Posaconazole Delayed-Release	7	12.5	12.5
Baricitinib	6	12.2	12.2
Tobramycin	14	11.5	11.5
Oseltamivir Phosphate	14	11.3	11.3
Vincristine Sulfate	15	10.1	10.1
Fludarabine Phosphate	20	10.1	10.1
Cyclophosphamide Injection, Solution	85	10.1	10.1
Cyclophosphamide	85	10.1	10.1
Cyclophosphamide For Injection	85	10.1	10.1
Cytarabine	30	10.0	10.0
Posaconazole	8	9.7	9.7
Daratumumab	18	8.9	8.9
Bendamustine Hcl	7	8.8	8.8
Efavirenz	5	8.8	8.8
Daptomycin	4	8.5	8.5
Etoposide	31	8.4	8.4
Thiotepa	4	8.2	8.2
Gefitinib	3	6.5	6.5
Remdesivir	4	5.9	5.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.